Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B
Authors:
- 11 June 2008
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 63 (4) , 643-650
Abstract
Purpose Cisplatin (CDDP) is one of the major chemotherapeutic drugs, but tumor cells’ acquired resistance to CDDP limits its therapeutic potentials. One of the main reasons of resistance is reduced drug accumulation. The mechanism by which tumor cells accumulate reduced CDDP is not well elucidated yet. The aim of this study was to investigate what regulates intracellular CDDP accumulation. Methods Six different types of oral squamous carcinoma cells were used in this study. Assessment of CDDP sensitivity was determined by measuring the ATP level of the cells. Intracellular CDDP and copper (Cu) accumulation were measured and CDDP efflux study was conducted. Assessment of Na+,K+-ATPase α and β subunits, ATP7A and ATP7B was done by western blotting. Specific activities of Na+,K+-ATPase and copper-transporting P-type ATPase (Cu2+-ATPase) were detected and a role of Na+,K+-ATPase inhibitor in intracellular CDDP accumulation was examined. Results Among the cells HSC-3 and BHY cells were found most CDDP-sensitive and CDDP-resistant, respectively. The most CDDP-sensitive HSC-3 cells exhibited an increased intracellular cisplatin accumulation, high Na+,K+-ATPase activity and over-expressed Na+,K+-ATPase α and β subunits, ATP7A and ATP7B, compared to the most CDDP-resistant BHY cells, but there were no such differences between the two in the CDDP efflux level or Cu2+-ATPase activity. Moreover, pretreatment with Na+,K+-ATPase inhibitor markedly reduced intracellular cisplatin accumulation. Conclusions Na+,K+-ATPase activity is responsible for regulating intracellular CDDP accumulation in oral squamous carcinoma cells rather than Cu2+-ATPase.Keywords
This publication has 35 references indexed in Scilit:
- Role of Na+, K+-ATPase α1 subunit in the intracellular accumulation of cisplatinCancer Chemotherapy and Pharmacology, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- The role of copper transporters in the development of resistance to Pt drugsJournal of Inorganic Biochemistry, 2004
- Cross-resistance to cisplatin in cells with acquired resistance to copperCancer Chemotherapy and Pharmacology, 2004
- The Copper Export Pump ATP7B Modulates the Cellular Pharmacology of Carboplatin in Ovarian Carcinoma CellsMolecular Pharmacology, 2003
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatinBritish Journal of Cancer, 1993
- Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesBritish Journal of Cancer, 1992
- Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon.Journal of General Physiology, 1989
- The (Na+ + K+)-activated ATPase Enzymatic and transport propertiesBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1979